Cargando…
Strategies for Dealing with Missing Data in Clinical Trials: From Design to Analysis
Randomized clinical trials are the gold standard for evaluating interventions as randomized assignment equalizes known and unknown characteristics between intervention groups. However, when participants miss visits, the ability to conduct an intent-to-treat analysis and draw conclusions about a caus...
Autores principales: | Dziura, James D., Post, Lori A., Zhao, Qing, Fu, Zhixuan, Peduzzi, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767219/ https://www.ncbi.nlm.nih.gov/pubmed/24058309 |
Ejemplares similares
-
Home pregnancy tests for iPLEDGE: ethically dealing with potential falsifications
por: Schwartzman, Gabrielle, et al.
Publicado: (2023) -
Public involvement and engagement in big data research: protocol for a scoping review and a systematic review of delivery and effectiveness of strategies for involvement and engagement
por: Teodorowski, Piotr, et al.
Publicado: (2021) -
Do protocols for new randomised trials take previous similar trials into account? Cohort study of contemporary trial protocols
por: Paludan-Müller, Asger Sand, et al.
Publicado: (2019) -
Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis
por: Axson, Sydney A, et al.
Publicado: (2021) -
Dissemination of trial results to participants in phase III pragmatic clinical trials: an audit of trial investigators intentions
por: Raza, M Zulfiqar, et al.
Publicado: (2020)